Annovis Bio announces addition of four new executives to leadership team

Annovis Bio announces the addition of four accomplished professionals to its executive team. Mark White Appointed Chief Business Officer – Currently a member of our Board of Directors, Mark White brings a wealth of global pharmaceutical marketing, business development, and sales experience to his new role as Chief Business Officer. Alexander Morin, Ph.D., Appointed Director of Strategic Communications – He has previously held the position of account executive at a boutique public relations firm. Hilda Maibach appointed Senior Vice President of Statistics – Maibach brings more than 30 years of experience in all aspects of clinical and observational studies in Oncology, Infectious Disease, Metabolic disorders and Central Nervous System Disorders. Blake Jensen appointed Head of Quality – Blake Jensen has over 20 years of experience in Quality within contract service providers and emerging biopharma companies, as well as previously working as an investigator for the U.S. FDA.